Blog

Revolutionizing Protein Purification with AI
π€ Researchers in Austria 𧬠are using artificial intelligence to describe the 3D structure of therapeutic proteins. π¬ π The AI helps design processes for purifying advanced therapies during manufacturing βοΈ. π Improve process development and understand protein biology using AI in the future. π

Revolutionizing Vaccine Development: Faster and Cheaper with Modeling
π Computer modeling techniques can revolutionize the vaccine sector, but harmonized guidelines are crucial for their success.

Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
π’ Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. πΌππͺπ

Streamlining GMP Implementation for Biotech Industry
π Simplifying GMP implementation with a risk-based approach to single-use technology in the biotechnology industry. πΌ

Cell and Gene Therapy: $82B Market by 2032 – Trends Challenges and Innovations
π° The global cell and gene therapy market is expected to reach $82.24 billion by 2032, with a current size of $15.54 billion in 2022. - Precedence Research π§« π¬ Gene therapy is seeing a rise in gene editing therapeutics, but cost and access remain challenges. π π Autologous CAR-T cell therapies are moving to earlier treatment stages, while allogeneic cell therapies and solid tumor therapies are being developed. π€ πΌ Collaboration and flexible regulatory pathways are key to advancing the industry and delivering therapies to patients. πͺ

CordenPharma Revolutionizes Drug Delivery with pHLIP LNP Platform
πΌ CordenPharma partners with pHLIP LNP platform to revolutionize drug delivery and expand capabilities in biotechnology. πππ€

Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
π Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. π

Uncovering the Perfect Price for CGT: A Global Quest
ππ° Global collaboration is essential to strike a balance between affordable and sustainable price points in the CGT industry.

Sleep Tech Startup Onera Health Raises $32M in Funding
π’ Sleep diagnostics specialist Onera Health raises β¬30m ($32m) in Series C round, accelerating manufacturing and expanding devices. π€π°






